Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.

Qure (QURE) announced that the Independent Data Monitoring Committee for EPISOD1, uniQure’s Phase I/II clinical trial of AMT-162, an ...

A new study published in Drug Design, Development and Therapy suggests that cannabidiol (CBD) may help protect the heart from ...

Financial writer discusses MGX's gene editing technology, cash runway, and lack of clinical data for potential future ...

A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...

A research group led by Kazunobu Sawamoto, a professor at Nagoya City University and National Institute for Physiological Sciences, and Koya Kawase, a pediatric doctor at Nagoya City University ...

The Phase Ib trial is set to test a gene therapy designed to target a rare disorder that causes muscle and respiratory failure.

This is a useful study that seeks to address the role of the TET family of DNA demethylation enzymes in pancreatic beta cell senescence in the context of type 2 diabetes (T2DM). Although the concepts ...

The TP53 gene is a gene that is mutated in many cancers. It is the most common gene mutation found in cancer cells. A tumor-suppressor gene, TP53 codes for a protein that inhibits the development and ...

The NYC show is at Knockdown Center on April 3. Tickets to that and all dates go on sale Friday, January 24 at 10 AM local, with a presale starting Tuesday, January 21 at 10 AM local.

SAN JOSE — Fire crews responded to a two-alarm fire at a barn in San Jose on Monday afternoon, bringing the flames under control in less than an hour. Related Articles Crashes and Disasters ...